Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 21, 2009 - Issue 5
428
Views
73
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006

, , , &
Pages 575-582 | Received 25 Oct 2007, Published online: 14 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Jesse B. Fletcher, Kirsty A. Clark & Cathy J. Reback. (2021) Depression and HIV transmission risk among methamphetamine-using men who have sex with men. Addiction Research & Theory 29:3, pages 263-270.
Read now
Sean P. Colyer, David M. Moore, Zishan Cui, Julia Zhu, Heather L. Armstrong, Matthew Taylor, Joshua Edward, Terry Howard, Chad Dickie, Gbolahan Olarewaju, Julio S.G Montaner, Robert S. Hogg, Eric A. Roth & Nathan J. Lachowsky. (2020) Crystal Methamphetamine Use and Initiation among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV in a Treatment as Prevention Environment. Substance Use & Misuse 55:14, pages 2428-2437.
Read now
Brooke Cheng, Jordan M. Sang, Zishan Cui, Nicanor Bacani, Heather L. Armstrong, Julia Zhu, Julius Elefante, Gbolahan Olarewaju, Kiffer G. Card, Everett Blackwell, Nathan J. Lachowsky, Robert S. Hogg, Eric A. Roth & David M. Moore. (2020) Factors Associated with Cessation or Reduction of Methamphetamine Use among Gay, Bisexual, and Other Men Who Have Sex with Men (gbMSM) in Vancouver Canada. Substance Use & Misuse 55:10, pages 1692-1701.
Read now
Huan Wang, Angela Chia-Chen Chen, Shaoping Wan & Hong Chen. (2019) Status and associated factors of self-management in people living with HIV/AIDS in Liangshan area, China: a cross-sectional study. Patient Preference and Adherence 13, pages 863-870.
Read now
Matthew J. Mimiaga, Elizabeth F. Closson, David W. Pantalone, Steven A. Safren & Jennifer A. Mitty. (2019) Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection. Psychology, Health & Medicine 24:3, pages 374-381.
Read now
Elizabeth F. Closson, Jennifer A. Mitty, Jowanna Malone, Kenneth H. Mayer & Matthew J. Mimiaga. (2018) Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study. AIDS Care 30:2, pages 191-198.
Read now
Deborah L. Jones, Mar Lucas, Inés Arístegui, Alejandra Bordato, Graciela Fernandez-Cabanillas, Virginia Zalazar, Omar Sued, Diego Cecchini, Isabel Cassetti, Pedro Cahn, Lina Bofill & Stephen M. Weiss. (2016) Implementation and uptake of the Conexiones y Opciones en la Argentina intervention: feasibility and acceptability. AIDS Care 28:10, pages 1287-1295.
Read now
Jenny K. Cohen, Glenn-Milo Santos, Nicholas J. Moss, Phillip O. Coffin, Nikolas Block & Jeffrey D. Klausner. (2016) Regular clinic attendance in two large San Francisco HIV primary care settings. AIDS Care 28:5, pages 579-584.
Read now
Jessica L. Montoya, Jordan Cattie, Erin Morgan, Steven Paul Woods, Mariana Cherner, David J. Moore, J. Hampton Atkinson, Igor Grant & The Translational Methamphetamine AIDS Research Center (TMARC) Group. (2016) The impact of age, HIV serostatus and seroconversion on methamphetamine use. The American Journal of Drug and Alcohol Abuse 42:2, pages 168-177.
Read now
Santosh Kumar, PSS Rao, Ravindra Earla & Anil Kumar. (2015) Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opinion on Drug Metabolism & Toxicology 11:3, pages 343-355.
Read now
DavidJ. Moore, Kaitlin Blackstone, Steven Paul Woods, RonaldJ. Ellis, J. Hampton Atkinson, RobertK. Heaton, Igor Grant & the HNRC Group and the TMARC Group. (2012) Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care 24:12, pages 1504-1513.
Read now

Articles from other publishers (62)

Omeid Heidari, Kayla Tormohlen, Derek T. DangerfieldIIII, Karin E. Tobin, Jason E Farley & Shoshana V. Aronowitz. (2022) Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review. Journal of Nursing Scholarship 55:3, pages 605-622.
Crossref
Ye Huang, Nam V. Nguyen, Danny A. Mammo, Thomas A. Albini, Brent R. Hayek, Brent D. Timperley, Ronald R. Krueger & Steven Yeh. (2023) Vision health perspectives on Breaking Bad: Ophthalmic sequelae of methamphetamine use disorder. Frontiers in Toxicology 5.
Crossref
Chiara Brombin, Sabrina Bagaglio, Federica Cugnata, Antonella Castagna, Caterina Uberti-Foppa, Stefania Salpietro, Clelia Di Serio & Giulia Morsica. (2022) Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models. Scientific Reports 12:1.
Crossref
Ya Zheng, Benjamin Reiner, Jianuo Liu, Linda Xu & Huangui Xiong. (2022) Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders. Neurobiology of Disease 168, pages 105712.
Crossref
Francis Lee, Daniel Sheeler, Anna Hotton, Natascha Del Vecchio, Rey Flores, Kayo Fujimoto, Nina Harawa, John A. Schneider & Aditya S. Khanna. (2022) Stimulant use interventions may strengthen ‘Getting to Zero’ HIV elimination initiatives in Illinois: Insights from a modeling study. International Journal of Drug Policy 103, pages 103628.
Crossref
Alexis V. Rivera, Graham Harriman, Sidney A. Carrillo & Sarah L. Braunstein. (2020) Trends in Methamphetamine Use Among Men Who Have Sex with Men in New York City, 2004–2017. AIDS and Behavior 25:4, pages 1210-1218.
Crossref
Buyisile Chibi, Neusa F. Torres, Zinhle P. Sokhela & Tivani P. Mashamba-Thompson. (2020) Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review. International Journal of Evidence-Based Healthcare 18:1, pages 5-23.
Crossref
B. Chibi, N.F. Torres, Z.P. Sokhela & T.P. Mashamba-Thompson. (2019) Prescription drug diversion among people living with HIV: a systematic scoping review. Public Health 177, pages 26-43.
Crossref
Erik D. Storholm, Laura M. Bogart, Matt G. Mutchler, David J. Klein, Bonnie Ghosh-Dastidar, Bryce McDavitt & Glenn J. Wagner. (2018) Antiretroviral Adherence Trajectories Among Black Americans Living with HIV. AIDS and Behavior 23:8, pages 1985-1997.
Crossref
E. M. Chumakov, N. N. Petrova & V. V. Rassokhin. (2019) COMPULSIVE SEXUAL BEHAVIOUR AS A RISK FACTOR FOR HIV. HIV Infection and Immunosuppressive Disorders 11:1, pages 7-15.
Crossref
Anthony T. Fojo, Catherine R. Lesko, Keri L. Calkins, Richard D. Moore, Mary E. McCaul, Heidi E. Hutton, William C. Mathews, Heidi Crane, Katerina Christopoulos, Karen Cropsey, Michael J. Mugavero, Kenneth Mayer, Brian W. Pence, Bryan Lau & Geetanjali Chander. (2018) Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?. AIDS and Behavior 23:3, pages 580-591.
Crossref
P. Barrett, K. O’Donnell, M. Fitzgerald, A.J. Schmidt, F. Hickson, M. Quinlan, P. Keogh, L. O’Connor, D. McCartney & D. Igoe. (2019) Drug use among men who have sex with men in Ireland: Prevalence and associated factors from a national online survey. International Journal of Drug Policy 64, pages 5-12.
Crossref
R. Colby Passaro, Keenan Ramsey, Eddy R. Segura, Jordan E. Lake, Cathy J. Reback, Jesse L. Clark & Steve Shoptaw. (2019) Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug and Alcohol Dependence 195, pages 164-169.
Crossref
Rob J. Fredericksen, M. Walcott, F. M. Yang, L. E. Gibbons, E. Fitzsimmons, S. Brown, K. H. Mayer, T. C. Edwards, S. Loo, C. Gutierrez, E. Paez, L. Dant, W. C. Mathews, M. J. Mugavero, D. L. Patrick, P. K. Crane & H. M. Crane. (2018) Circumstances Surrounding High-risk Sexual Experiences Among Primary Care Patients Living With and Without HIV. Journal of General Internal Medicine 33:12, pages 2163-2170.
Crossref
Mark S Dworkin, Apurba Chakraborty, Diana Zychowski, Geri Donenberg, Richard Novak & Robert Garofalo. (2018) Self-efficacy and ability to read as factors associated with antiretroviral therapy adherence in an HIV-infected population. International Journal of STD & AIDS 29:12, pages 1154-1164.
Crossref
Perrine Roux, Lisa Fressard, Marie Suzan-Monti, Julie Chas, Luis Sagaon-Teyssier, Catherine Capitant, Laurence Meyer, Cécile Tremblay, Daniela Rojas-Castro, Gilles Pialoux, Jean-Michel Molina & Bruno Spire. (2018) Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 79:2, pages e69-e75.
Crossref
Rob J. Fredericksen, Kenneth H. Mayer, Laura E. Gibbons, Todd C. Edwards, Frances M. Yang, Melonie Walcott, Sharon Brown, Lydia Dant, Stephanie Loo, Cristina Gutierrez, Edgar Paez, Emma Fitzsimmons, Albert W. Wu, Michael J. Mugavero, William C. Mathews, William B. Lober, Mari M. Kitahata, Donald L. Patrick, Paul K. Crane & Heidi M. Crane. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. Journal of General Internal Medicine 33:10, pages 1661-1668.
Crossref
James P. Kesby, Jerel A. Fields, Ariel Chang, Hamza Coban, Cristian L. Achim & Svetlana Semenova. (2018) Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice. Behavioural Brain Research 349, pages 73-79.
Crossref
Wei Jiang, Zhenwu Luo, Lisa Martin, Zhuang Wan, Pingfu Fu, Amanda Wagner, Binhua Ling, Sonya L. Heath, Azizul Haque & Aimee McRae-Clark. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Current HIV Research 16:2, pages 143-150.
Crossref
David J. Moore, Elizabeth C. Pasipanodya, Anya Umlauf, Alexandra S. Rooney, Ben Gouaux, Colin A. Depp, J. Hampton Atkinson & Jessica L. Montoya. (2018) Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Drug and Alcohol Dependence 189, pages 154-160.
Crossref
Igor Grabovac, Michael Meilinger, Horst Schalk, Birgit Leichsenring & Thomas Ernst Dorner. (2018) Prevalence and Associations of Illicit Drug and Polydrug Use in People Living with HIV in Vienna. Scientific Reports 8:1.
Crossref
Claire Edmundson, Ellen Heinsbroek, Rachel Glass, Vivian Hope, Hamish Mohammed, Martin White & Monica Desai. (2018) Sexualised drug use in the United Kingdom (UK): A review of the literature. International Journal of Drug Policy 55, pages 131-148.
Crossref
Richard S. Schottenfeld, Marek C. Chawarski, Mehmet Sofuoglu, Weng-Tink Chooi, Norzarina M. Zaharim, M. Azhar M. Yasin, Imran Ahmad, Sharifah Zubaidiah Syed Jaapar & B. Kasinather Vicknasingam. (2018) Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial. Drug and Alcohol Dependence 186, pages 130-137.
Crossref
Allison Carter, Eric Abella Roth, Erin Ding, M-J Milloy, Mary Kestler, Shahab Jabbari, Kath Webster, Alexandra de Pokomandy, Mona Loutfy & Angela Kaida. (2017) Substance Use, Violence, and Antiretroviral Adherence: A Latent Class Analysis of Women Living with HIV in Canada. AIDS and Behavior 22:3, pages 971-985.
Crossref
J Carlo Hojilla, David Vlahov, David V Glidden, K Rivet Amico, Megha Mehrotra, Robert Hance, Robert M Grant & Adam W Carrico. (2018) Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. Journal of the International AIDS Society 21:3, pages e25103.
Crossref
Alan R. LifsonSale WorknehTibebe ShenieDesalegn Admassu AyanaZenebe MelakuLemlem BezabihHiwot Tekle WaktolaBehailu DagneRose HilkKen C. WintersLucy Slater. (2017) Frequent Use of Khat, an Amphetamine-Like Substance, as a Risk Factor for Poor Adherence and Lost to Follow-Up Among Patients New to HIV Care in Ethiopia. AIDS Research and Human Retroviruses 33:10, pages 995-998.
Crossref
Jianuo Liu, Enquan Xu, Guihua Tu, Han Liu, Jiangtao Luo & Huangui Xiong. (2017) Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K + current. Molecular and Cellular Neuroscience 82, pages 167-175.
Crossref
Ana Sanchez & Marcus Kaul. (2017) Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. Brain Sciences 7:12, pages 25.
Crossref
April D. Thames & Jacob D. Jones. 2017. Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS 283 313 .
Jaclyn M. White Hughto, Janna R. Gordon & Matthew J. Mimiaga. 2017. Understanding Prevention for HIV Positive Gay Men. Understanding Prevention for HIV Positive Gay Men 151 192 .
Deborah L. Jones, Omar Sued, Diego Cecchini, Lina Bofill, Ryan Cook, Mar Lucas, Alejandra Bordato, Isabel Cassetti, Pedro Cahn & Stephen M. Weiss. (2015) Improving Adherence to Care Among “Hard to Reach” HIV-Infected Patients in Argentina. AIDS and Behavior 20:5, pages 987-997.
Crossref
Keith J Horvath, Dawit Alemu, Thu Danh, Jason V Baker & Adam W Carrico. (2016) Creating Effective Mobile Phone Apps to Optimize Antiretroviral Therapy Adherence: Perspectives From Stimulant-Using HIV-Positive Men Who Have Sex With Men. JMIR mHealth and uHealth 4:2, pages e48.
Crossref
Richard Ma & Seán Perera. (2015) Safer ‘chemsex’: GPs’ role in harm reduction for emerging forms of recreational drug use. British Journal of General Practice 66:642, pages 4-5.
Crossref
Pouya Azar, Evan Wood, Paul Nguyen, Maxo Luma, Julio Montaner, Thomas Kerr & M-J Milloy. (2015) Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infectious Diseases 15:1.
Crossref
Ryan Colby Passaro, Jui Pandhare, Han-Zhu Qian & Chandravanu Dash. (2015) The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. Journal of Neuroimmune Pharmacology 10:3, pages 477-486.
Crossref
James P Kesby, Robert K Heaton, Jared W Young, Anya Umlauf, Steven P Woods, Scott L Letendre, Athina Markou, Igor Grant & Svetlana Semenova. (2015) Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Neuropsychopharmacology 40:8, pages 1899-1909.
Crossref
James P. Kesby, Athina Markou, Svetlana Semenova, Igor Grant, Ronald J. Ellis, Scott L. Letendre, Cristian L. Achim, Steven Paul Woods, Aaron M. Carr, Scott L. Letendre, Ronald J. Ellis, Rachel Schrier, Robert K. Heaton, J. Hampton Atkinson, Mariana Cherner, Thomas D. Marcotte, Erin E. Morgan, Gregory Brown, Terry Jernigan, Anders Dale, Thomas Liu, Miriam Scadeng, Christine Fennema-Notestine, Sarah L. Archibald, Cristian L. Achim, Eliezer Masliah, Stuart Lipton, Virawudh Soontornniyomkij, Anthony C. Gamst, Clint Cushman, Ian Abramson, Florin Vaida, Reena Deutsch, Anya Umlauf, J. Hampton Atkinson, Jennifer Marquie-Beck, Arpi Minassian, William Perry, Mark Geyer, Brook Henry, Jared Young, Amanda B. Grethe, Martin Paulus, Ronald J. Ellis, Sheldon Morris, David M. Smith, Igor Grant, Svetlana Semenova, Athina Markou, James P. Kesby & Marcus Kaul. (2015) Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice. European Neuropsychopharmacology 25:1, pages 141-150.
Crossref
Keith A. Hermanstyne, Glenn-Milo Santos, Eric Vittinghoff, Deirdre Santos, Grant Colfax & Phillip Coffin. (2014) Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses. Drug and Alcohol Dependence 143, pages 277-280.
Crossref
James P. Kesby, David T. Hubbard, Athina Markou & Svetlana Semenova. (2014) Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. Addiction Biology 19:4, pages 593-605.
Crossref
Glenn-Milo Santos, Jenna Rapues, Erin C. Wilson, Oscar Macias, Tracey Packer, Grant Colfax & Henry Fisher Raymond. (2014) Alcohol and substance use among transgender women in San Francisco: Prevalence and association with human immunodeficiency virus infection. Drug and Alcohol Review 33:3, pages 287-295.
Crossref
Jessica L. Montoya, Anya Umlauf, Ian Abramson, Jayraan Badiee, Steven Paul Woods, J. Hampton Atkinson, Igor Grant & David J. Moore. (2013) Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: A five-year longitudinal analysis. Journal of Affective Disorders 151:2, pages 728-737.
Crossref
Matthew J. MimiagaSari L. ReisnerChris GrassoHeidi M. CraneSteven A. SafrenMari M. KitahataJoseph E. SchumacherW. Christopher MathewsKenneth H. Mayer. (2013) Substance Use Among HIV-Infected Patients Engaged in Primary Care in the United States: Findings From the Centers for AIDS Research Network of Integrated Clinical Systems Cohort. American Journal of Public Health 103:8, pages 1457-1467.
Crossref
Shauna Stahlman, Marjan Javanbakht, Ali Stirland, Sarah Guerry & Pamina M. Gorbach. (2013) Methamphetamine Use Among Women Attending Sexually Transmitted Disease Clinics in Los Angeles County. Sexually Transmitted Diseases 40:8, pages 632-638.
Crossref
Jeffrey T. Parsons, William J. Kowalczyk, Michael Botsko, Julia Tomassilli & Sarit A. Golub. (2013) Aggregate Versus Day Level Association Between Methamphetamine Use and HIV Medication Non-adherence Among Gay and Bisexual Men. AIDS and Behavior 17:4, pages 1478-1487.
Crossref
David J. Moore, Jessica L. Montoya, Kaitlin Blackstone, Alexandra Rooney, Ben Gouaux, Shereen Georges, Colin A. Depp, J. Hampton Atkinson & The TMARC Group. (2013) Preliminary Evidence for Feasibility, Use, and Acceptability of Individualized Texting for Adherence Building for Antiretroviral Adherence and Substance Use Assessment among HIV-Infected Methamphetamine Users. AIDS Research and Treatment 2013, pages 1-11.
Crossref
Keith J. Horvath, Adam W. Carrico, Jane Simoni, Edward W. Boyer, K. Rivet Amico & Andy E. Petroll. (2013) Engagement in HIV Medical Care and Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with Men. AIDS Research and Treatment 2013, pages 1-11.
Crossref
Erol Digiusto & Patrick Rawstorne. (2013) Is it really crystal clear that using methamphetamine (or other recreational drugs) causes people to engage in unsafe sex?. Sexual Health 10:2, pages 133.
Crossref
Gurudutt Pendyala, James L. Buescher & Howard S. Fox. (2012) Methamphetamine and Inflammatory Cytokines Increase Neuronal Na+/K+-ATPase Isoform 3: Relevance for HIV Associated Neurocognitive Disorders. PLoS ONE 7:5, pages e37604.
Crossref
Taylor Clark, Carina Marquez, C. Bradley Hare, Malcolm D. John & Jeffrey D. Klausner. (2010) Methamphetamine Use, Transmission Risk Behavior and Internet Use Among HIV-Infected Patients in Medical Care, San Francisco, 2008. AIDS and Behavior 16:2, pages 396-403.
Crossref
Radha RajasinghamMatthew J. MimiagaJaclyn M. WhiteMegan M. PinkstonRachel P. BadenJennifer A. Mitty. (2012) A Systematic Review of Behavioral and Treatment Outcome Studies Among HIV-Infected Men Who Have Sex with Men Who Abuse Crystal Methamphetamine. AIDS Patient Care and STDs 26:1, pages 36-52.
Crossref
Sascha R Ellington, Caroline C King & Athena P Kourtis. (2011) Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition. Future Virology 6:12, pages 1451-1469.
Crossref
Adam Gonzalez, Jennifer Barinas & Conall O’Cleirigh. (2011) Substance Use: Impact on Adherence and HIV Medical Treatment. Current HIV/AIDS Reports 8:4, pages 223-234.
Crossref
Nadia Fairbairn, Thomas Kerr, M.-J. Milloy, Ruth Zhang, Julio Montaner & Evan Wood. (2011) Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addictive Behaviors 36:7, pages 762-763.
Crossref
Saurabh Gupta, Chad A. Bousman, Gursharan Chana, Mariana Cherner, Robert K. Heaton, Reena Deutsch, Ronald J. Ellis, Igor Grant & Ian P. Everall. (2011) Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings. Journal of NeuroVirology 17:3, pages 239-247.
Crossref
Vishnudutt Purohit, Rao S. Rapaka, Paul Schnur & David Shurtleff. (2011) Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART). Life Sciences 88:21-22, pages 909-916.
Crossref
Pamina M Gorbach, Robert E Weiss, Robin Jeffries, Marjan Javanbakht, Lydia N Drumright, Eric S Daar & Susan J Little. (2011) Behaviors of Recently HIV-Infected Men Who Have Sex With Men in the Year Postdiagnosis: Effects of Drug Use and Partner Types. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:2, pages 176-182.
Crossref
Katerina A. Christopoulos, Moupali Das & Grant N. Colfax. (2011) Linkage and Retention in HIV Care among Men Who Have Sex with Men in the United States. Clinical Infectious Diseases 52:suppl_2, pages S214-S222.
Crossref
Jamila K Stockman & Steffanie A Strathdee. (2010) HIV Among People Who Use Drugs: A Global Perspective of Populations at Risk. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:Supplement 1, pages S17-S22.
Crossref
Vishnudutt Purohit, Rao S. Rapaka & David Shurtleff. (2010) Mother-to-Child Transmission (MTCT) of HIV and Drugs of Abuse in Post-Highly Active Antiretroviral Therapy (HAART) Era. Journal of Neuroimmune Pharmacology 5:4, pages 507-515.
Crossref
Grant Colfax, Glenn-Milo Santos, Priscilla Chu, Eric Vittinghoff, Andreas Pluddemann, Suresh Kumar & Carl Hart. (2010) Amphetamine-group substances and HIV. The Lancet 376:9739, pages 458-474.
Crossref
Olamide Dosekun & Julie Fox. (2010) An overview of the relative risks of different sexual behaviours on HIV transmission. Current Opinion in HIV and AIDS 5:4, pages 291-297.
Crossref
Moupali Das, Deirdre Santos, Tim Matheson, Glenn-Milo Santos, Priscilla Chu, Eric Vittinghoff, Steve Shoptaw & Grant N Colfax. (2010) Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. AIDS 24:7, pages 991-1000.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.